strips
Research Use OnlyCJC/IPA Oral Strip
An oral dissolvable strip formulation containing CJC-1295 (a synthetic GHRH analogue) and Ipamorelin (a selective ghrelin/GHS-R1a receptor agonist). Characterized in pre-clinical literature for their combined action on growth-hormone secretagogue pathways. Sold for laboratory research and identification purposes only. Not for human consumption.
Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Technical Data
Specifications
Technical Details
Quality Assurance
Certificate of Analysis
Certificate of Analysis
COA documentation is being prepared for this product.
Contact research@roehn.co for batch-specific testing data.
Research Overview
About CJC/IPA Oral Strip
The CJC/IPA Strip delivers a precision blend of CJC-1295 and Ipamorelin — two growth hormone secretagogues that operate through complementary receptor pathways — in a convenient oral dissolvable format. CJC-1295, a synthetic GHRH analogue, stimulates pituitary somatotrophs through the growth hormone-releasing hormone receptor, while Ipamorelin acts as a selective GHS-R1a agonist through the ghrelin signaling pathway.
This dual-receptor approach has been studied for its potential to produce synergistic GH pulse amplification exceeding either agent alone. Research areas of interest include IGF-1 elevation and body composition optimization, recovery enhancement and sleep architecture support, and the broader implications of sustained growth hormone secretagogue activity on metabolic health and cellular renewal.
Now available in sublingual strip format, this formulation bypasses digestive breakdown for enhanced peptide bioavailability. Each strip is manufactured in a cGMP-certified facility with third-party testing — no reconstitution, no refrigeration, no injections required.
